Document Detail


Contribution of adenosine to compensatory dilation in hypoperfused contracting human muscles is independent of nitric oxide.
MedLine Citation:
PMID:  21292838     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We previously demonstrated that nitric oxide (NO) contributes to compensatory vasodilation in the contracting human forearm subjected to acute hypoperfusion. We examined the potential role of an adenosine-NO interaction to this response in 17 male subjects (25 ± 2 yr). In separate protocols subjects performed rhythmic forearm exercise (20% of maximum) while hypoperfusion was evoked by balloon inflation in the brachial artery above the elbow. Each trial included exercise before inflation, exercise with inflation, and exercise after deflation (3 min each). Forearm blood flow (FBF; ultrasound) and local [brachial artery catheter pressure (BAP)] and systemic [mean arterial pressure (MAP); Finometer] arterial pressure were measured. In protocol 1 (n = 10), exercise was repeated during nitric oxide synthase inhibition [N(G)-monomethyl-L-arginine (L-NMMA)] alone and during L-NMMA-aminophylline (adenosine receptor blockade) administration. In protocol 2, exercise was repeated during aminophylline alone and during aminophylline-L-NMMA. Forearm vascular conductance (FVC; ml·min(-1)·100 mmHg(-1)) was calculated from blood flow (ml/min) and BAP (mmHg). Percent recovery in FVC during inflation was calculated as (steady-state inflation + exercise value - nadir)/[steady-state exercise (control) value - nadir]. In protocol 1, percent recovery in FVC was 108 ± 8% during the control (no drug) trial. Percent recovery in FVC was attenuated with inhibition of NO formation alone (78 ± 9%; P < 0.01 vs. control) and was attenuated further with combined inhibition of NO and adenosine (58 ± 9%; P < 0.01 vs. L-NMMA). In protocol 2, percent recovery was reduced with adenosine receptor blockade (74 ± 11% vs. 113 ± 6%, P < 0.01) compared with control drug trials. Percent recovery in FVC was attenuated further with combined inhibition of adenosine and NO (48 ± 11%; P < 0.05 vs. aminophylline). Our data indicate that adenosine contributes to compensatory vasodilation in an NO-independent manner during exercise with acute hypoperfusion.
Authors:
Darren P Casey; Michael J Joyner
Related Documents :
12369738 - Effect of different muscle shortening velocities during prolonged incremental cycling e...
16380698 - Exercise intensity and its effects on thyroid hormones.
7293668 - Iodine metabolism and the effect of tsh in thyroid glands of early bovine embryos.
10984298 - Exercise capacity and hormonal response in adults with childhood onset growth hormone d...
6352578 - Effects of exercise and lack of exercise on glucose tolerance and insulin sensitivity.
22087518 - The prevalence of occupational asthma among denim bleachery workers in kayseri.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-02-03
Journal Detail:
Title:  Journal of applied physiology (Bethesda, Md. : 1985)     Volume:  110     ISSN:  1522-1601     ISO Abbreviation:  J. Appl. Physiol.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-12     Completed Date:  2011-09-30     Revised Date:  2012-05-01    
Medline Journal Info:
Nlm Unique ID:  8502536     Medline TA:  J Appl Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1181-9     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, Mayo Clinic Rochester, MN 55905, USA. casey.darren@mayo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adaptation, Physiological / physiology
Adenosine / metabolism*
Adult
Blood Flow Velocity / physiology
Humans
Male
Muscle Contraction*
Muscle, Skeletal / physiology*
Nitric Oxide / metabolism*
Physical Exertion / physiology*
Vasodilation / physiology*
Grant Support
ID/Acronym/Agency:
AR-55819/AR/NIAMS NIH HHS; HL-46493/HL/NHLBI NIH HHS; RR-024150/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 58-61-7/Adenosine
Comments/Corrections
Comment In:
J Appl Physiol. 2011 May;110(5):1154-5   [PMID:  21393475 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stre...
Next Document:  Biological aortic age derived from the arterial pressure waveform.